Loss of exclusivityMay 2034latest FDA-listed patent expiry
CompanyHAISCO-USA PHARMACEUTICALS INC
Drug detail
Brand name
CYPSEDO
Active ingredient
CIPEPOFOL
Strength
50MG/20ML (2.5MG/ML)
Dosage form
EMULSION
Route
INTRAVENOUS
Modality
Small molecule
FDA approval
August 2026
Marketing status
RX
Listed patents
Patent
Expires
Type
10729666
May 2034
product
9517988
May 2034
substance
Regulatory exclusivity
Code
Expires
NCE
August 2031
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.